Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
TME Pharma announces receipt of agreements in principle to extend certain bond agreements
-
Carmila Sells €37.3m of Non-Strategic Assets in Spain and Exceeds Its 2025 Disposal Target
-
Accession Therapeutics doses first patient in Phase 1 clinical trial of TROCEPT-01 (ATTR-01), a novel cancer immunotherapy
-
Secure Remote Printing of Spare Parts for the Oil and Gas Industry: Assembrix, HP, Sparely, and Korall Engineering Complete Global Series
-
Pulsar Helium to Host Virtual Site Visit and Q&A with CEO Thomas Abraham-James and Helium-3 Advisor Dr Peter Barry
-
FOTRIC Launches TD2 Geek — The World’s First Smartphone Acoustic Imager That Lets You See Sound Without Draining Your Phone
-
Allied Biofuels and Praj Industries Signs MoU to Establish Central Asia’s Largest Ethanol Refinery in Uzbekistan, Fueling Allied Biofuels SAF and e-SAF plans
-
Pulsar Helium to Host Virtual Site Visit and Q&A with CEO Thomas Abraham-James and Helium-3 Advisor Dr Peter Barry
-
Corporate Update
-
GEVORKYAN, a.s. to release Q3 2025 financial results on November 19, 2025
-
Bureau Veritas appoints Santiago Arias Duval as Executive Vice-President for the Americas region
-
NBPE Announces Transaction in Own Shares
-
OSB GROUP PLC - Transaction in Own Shares
-
Haffner Energy Unveils the H6 Generation
-
Transaction in Own Shares
-
Modern Card Issuing Platforms Market to Surpass $4.2 Billion by 2030, as Juniper Research Reveals Global Leaders Driving Fintech Innovation
-
Ragnarok Online Landverse America - Pre-Registration Now Live for Latin America and North America
-
James M. O’Brien Appointed Chief Financial Officer at Mesoblast
-
Share repurchase programme: Transactions of week 46 2025
-
MassMutual and Barings Announce Investment by MS&AD Insurance Group Holdings for 18% Stake in Barings
-
Ascend Vitality Expands National Telehealth Network to Provide Physician-Directed Access to Compounded Peptide Therapies
-
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
-
Technip Energies to supply liquefied CO2 marine loading arms for phase 2 of the Northern Lights project in Norway
-
From InnQuest to roommaster - A New Era of Unified, AI-Driven Hospitality Technology Begins
-
Sampo plc’s share buybacks 14 November 2025
-
Amundi : Continuation of the long-term partnership with Societe Generale
-
HIVE Delivers Record Q2 with 285% Revenue Growth as Bitcoin Production and BUZZ HPC Hit New Highs Powered by a 223% Year-Over-Year Increase in Operational Bitcoin Hashrate, Resulting in ~300% Growth i
-
HIVE Delivers Record Q2 with 285% Revenue Growth as Bitcoin Production and BUZZ HPC Hit New Highs Powered by a 223% Year-Over-Year Increase in Operational Bitcoin Hashrate, Resulting in ~300% Growth i
-
HIVE Delivers Record Q2 with 285% Revenue Growth as Bitcoin Production and BUZZ HPC Hit New Highs Powered by a 223% Year-Over-Year Increase in Operational Bitcoin Hashrate, Resulting in ~300% Growth i
-
HIVE Delivers Record Q2 with 285% Revenue Growth as Bitcoin Production and BUZZ HPC Hit New Highs Powered by a 223% Year-Over-Year Increase in Operational Bitcoin Hashrate, Resulting in ~300% Growth i
-
HIVE Delivers Record Q2 with 285% Revenue Growth as Bitcoin Production and BUZZ HPC Hit New Highs Powered by a 223% Year-Over-Year Increase in Operational Bitcoin Hashrate, Resulting in ~300% Growth i
-
HIVE Digital Technologies Subsidiary, BUZZ High Performance Computing, Accelerates Canada's AI Industrial Revolution with Dell Technologies for its AI Cloud Expansion
-
Net asset value of the EfTEN United Property Fund as of 31.10.2025
-
JLL Receives Frost & Sullivan's 2025 APAC and Singapore Company of the Year Recognitions for Facility Management
-
Innate Pharma to Present at Jefferies Global Healthcare Conference
-
ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline
-
Deciphera Announces the Opening of a New Office in Zug, Switzerland
-
Incyte Announces Positive CHMP Opinion for Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)
-
Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic
-
VEON Commences USD 100 million Buyback Program
-
Agomab Announces Positive Topline Phase 2a Data for Ontunisertib in Fibrostenosing Crohn’s Disease
-
Start of Day Message
-
Pluxee maintains positive outlook for Fiscal 2026 after regulatory reform announced in Brazil
-
Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic
-
CFO Tania Micki to leave Tecan for new role in 2026
-
TGS Announces Pelotas Norte Phase I Multi-client Survey Offshore Brazil
-
Aktsiaselts Infortar own share acquisition transactions
-
$350,000 Thanksgiving Campaign Launches on Toobit
-
New Akkodis report finds enterprises see real AI productivity gains; scaling remains the barrier to ROI
-
Millennial Potash Reports Significant Increase In Resource Estimates: Measured + Indicated Resource is up by 275% and Inferred Resource is increased by 210% at its Flagship Banio Potash Project: Measu
